Individual factors like gut bacteria composition, dietary habits, protein intake, and digestive enzyme levels influence susceptibility
This occurs because semaglutide's appetite-suppressing effects reverse, gastric emptying returns to normal speed, and the metabolic adaptations that occur with weight loss (including reduced energy expenditure) persist
As a bariatric surgeon with over a decade of experience, Ive seen firsthand how powerful these medications can be when integrated into a comprehensive, physician-supervised plan
The goal of the study was to ascertain whether GI adverse events (GI AEs), such as nausea/vomiting, diarrhea, constipation, and dyspepsia (indigestion), during the dose escalation phase (baseline to week 12) and from baseline to the end of treatment, are responsible for the greater weight loss seen with semaglutide compared to other GLP-1RAs